Speaker Profile
Product Manager, Lexogen
Biography
Eva earned her masters degree at the Technical University of Munich (TUM) in collaboration with the University of Vienna and the Vienna Biocenter Core Facility. Her research focused on optimizing CRISPRCas9 tools for precise knock-ins in mammalian cell lines. With a background in sales, she excels at addressing scientific challenges from a customer perspective, driven by a passion for finding tailored solutions. Eva brings this dedication to her role as Product Manager at Lexogen.
Talk
Lexogen - Leading NGS Services Provider for Cancer Drug Discovery
Lexogen is a leading sequencing services provider offering Innovative Sequencing Technologies for Drug Discovery and preclinical studies with end-to-end solutions for target identification and biomarker discovery from FFPE or blood samples and single cells.
Sequencing Technologies Showcase:
Lexogen
Lexogen is a leading company in RNA sequencing, providing innovative solutions for transcriptome analysis and RNA research. Our products and services are designed to meet the evolving needs of the scientific community, delivering end-to-end solutions for high-quality, reliable results. For more information, visit www.lexogen.com.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Sequencing Technologies Showcase will provide 15-30 minute speaking opportunities for selected companies working with the latest technologies in precision medicine to highlight their contributions to the field.
